1-9 of 9
Jérôme Jaubert
Close
Sort by
Journal Articles

1p22 and 1p32 Deletions Are Independent Prognosis Factors in Young Patients with Myeloma: The IFM Experience On 1195 Patients

Benjamin Hebraud, MD, Xavier Leleu, MD, PhD, Valerie lauwers-Cances, Murielle Roussel, MD, Gerald Marit, MD, Lionel Karlin, MD, Cyrille Hulin, MD, Catherine Gentil, Francois Guilhot, MD, Laurent Garderet, Thierry Lamy, MD, PhD, Sabine Brechignac, Brigitte Pegourie, MD, Jerome Jaubert, Mamoun Dib, Anne-Marie Stoppa, MD, Catherine Sebban, MD, Cecile Fohrer, Jean Fontan, MD, Christophe Fruchart, Didier Bouscary, Bernadette Corront, MD, Gerard Lepeu, MD, Jill Corre, Thierry Facon, MD, Michel Attal, MD, Philippe Moreau, MD, Herve avet-Loiseau, MD
Journal: Blood
Blood (2012) 120 (21): 933.
https://doi.org/10.1182/blood.V120.21.933.933
Published: 2012
Journal Articles

Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial

Brief Report
Philippe Moreau, Michel Attal, Brigitte Pégourié, Lucie Planche, Cyrille Hulin, Thierry Facon, Anne-Marie Stoppa, Jean-Gabriel Fuzibet, Bernard Grosbois, Chantal Doyen, Nicolas Ketterer, Catherine Sebban, Brigitte Kolb, Carine Chaleteix, Mamoun Dib, Laurent Voillat, Jean Fontan, Laurent Garderet, Jérôme Jaubert, Claire Mathiot, Dixie Esseltine, Hervé Avet-Loiseau, Jean-Luc Harousseau, for the IFM 2005-01 study investigators*
Journal: Blood
Blood (2011) 117 (11): 3041–3044.
https://doi.org/10.1182/blood-2010-08-300863
Published: 2011
Journal Articles

Transmission of leukemic donor cells by allogeneic stem cell transplantation in a context of familial CLL: should we screen donors for MBL?

Pascale Flandrin-Gresta, Mary Callanan, Nathalie Nadal, Jerome Jaubert, Jerome Cornillon, Denis Guyotat, Lydia Campos
Journal: Blood
Blood (2010) 116 (23): 5077–5078.
https://doi.org/10.1182/blood-2010-08-300673
Published: 2010
Journal Articles

Long-Term Maintenance with Lenalidomide Improves Progression Free Survival In Myeloma Patients with High-Risk Cytogenetics: An IFM Study

Hervé Avet-Loiseau, Denis Caillot, Gerald Marit, Valerie Lauwers-Cances, Murielle Roussel, Thierry Facon, Cyrille Hulin, Thierry Lamy, Brigitte Pegourie, Herve Maisonneuve, MD, Laurent Garderet, Philippe Moreau, Anne-Marie Stoppa, MD, Mamoun Dib, Jerome Jaubert, Philippe Casassus, MD, Claire Mathiot, Jean-Luc Harousseau, MD, Philippe Moreau, MD, Michel Attal
Journal: Blood
Blood (2010) 116 (21): 1944.
https://doi.org/10.1182/blood.V116.21.1944.1944
Published: 2010
Journal Articles

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years

Clinical Trials & Observations
Emmanuel Gyan, Charles Foussard, Philippe Bertrand, Patrick Michenet, Steven Le Gouill, Christian Berthou, Hervé Maisonneuve, Vincent Delwail, Rémi Gressin, Philippe Quittet, Jean-Pierre Vilque, Bernard Desablens, Jérôme Jaubert, Jean-François Ramée, Nina Arakelyan, Antoine Thyss, Cécile Moluçon-Chabrot, Roselyne Delépine, Noël Milpied, Philippe Colombat, Eric Deconinck
Journal: Blood
Blood (2009) 113 (5): 995–1001.
https://doi.org/10.1182/blood-2008-05-160200
Published: 2009
Journal Articles

The VIP-ABVD Regimen Is Not Superior to the CHOP 21 for the Treatment of Non Epidermotropic Peripheral T Cell Lymphoma. Final Results of the “LTP95” Protocol of the GOELAMS.

Remy Gressin, MD, Michel Peoch, MD, Eric Deconinck, MD, Philippe Casassus, MD, Bernard Desablens, MD, Delphine Senecal, MD, Philippe Quitet, MD, Jean Pierre Vilque, MD, Charles Foussard, MD, Houchingue Eghbali, MD, Jerome Jaubert, MD, Olivier Tournilhac, MD, Virginie Lucas, MD, Vincent Delwail, MD, Bachera Choufi, MD, Antoine Thyss, MD, Francoise Huguet, MD, Frederic Maloisel, MD, Bruno Richard, MD, Noel-Jean Milpied, MD, Philippe Colombat, MD
Journal: Blood
Blood (2006) 108 (11): 2464.
https://doi.org/10.1182/blood.V108.11.2464.2464
Published: 2006
Journal Articles

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS

Clinical Trials & Observations
Eric Deconinck, Charles Foussard, Noel Milpied, Philippe Bertrand, Patrick Michenet, Pascale Cornillet-LeFebvre, Martine Escoffre-Barbe, Herve Maisonneuve, Vincent Delwail, Remy Gressin, Eric Legouffe, Jean-Pierre Vilque, Bernard Desablens, Jerome Jaubert, Jean-François Ramee, Arash Jenabian, Antoine Thyss, Annick Le Pourhiet-Le Mevel, Philippe Travade, Roselyne Delepine, Philippe Colombat, GOELAMS
Journal: Blood
Blood (2005) 105 (10): 3817–3823.
https://doi.org/10.1182/blood-2004-10-3920
Published: 2005
Journal Articles

Randomized Clinical Trial Comparing Melphalan-Prednisone (MP), MP-Thalidomide (MP-THAL) and High-Dose Therapy Using Melphalan 100 MG/M 2 (MEL100) for Newly Diagnosed Myeloma Patients Aged 65–75 Years. Interim Analysis of the IFM 99-06 Trial on 350 Patients.

Thierry Facon, Jean Yves Mary, Cyril Hulin, Lofti Benboubker, Michel Attal, Jean Luc Harousseau, Brigitte Pegourie, Marc Renaud, Gaelle Guillerm, Laurent Voillat, Carine Chaleteix, Jacques Troncy, Mathieu Monconduit, Philippe Casassus, Herve Maisonneuve, Veronique Dorvaux, Jerome Jaubert, Mamoun Dib, Chantal Doyen
Journal: Blood
Blood (2004) 104 (11): 206.
https://doi.org/10.1182/blood.V104.11.206.206
Published: 2004
Journal Articles

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

Clinical Trials & Observations
Michel Leporrier, Sylvie Chevret, Bruno Cazin, Najda Boudjerra, Pierre Feugier, Bernard Desablens, Marie-José Rapp, Jerome Jaubert, Claudie Autrand, Marine Divine, Brigitte Dreyfus, Karim Maloum, Philippe Travade, Guillaume Dighiero, Jacques-Louis Binet, Claude Chastang
Journal: Blood
Blood (2001) 98 (8): 2319–2325.
https://doi.org/10.1182/blood.V98.8.2319
Published: 2001